Illustration of the lymphatic system. Credit: Shutterstock Melanoma cells release small extracellular packages containing the protein nerve growth factor receptor, which primes nearby lymph nodes for tumor metastases,... Read more
A highly portable and rapid prostate cancer screening kit could provide early warning to populations with higher incidence of prostate cancer and particularly those with limited access to health care, such as African... Read more
Aggressive and relatively common lymphomas called diffuse large B cell lymphomas (DLBCLs) have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves, according to a study... Read more
Depleting copper levels may reduce the production of energy that cancer cells need to travel and establish themselves in other parts of the body by a process referred to as metastasis, according to a new study by... Read more
Weill Cornell Medicine has been awarded a nearly $6.5 million, four-year grant from the Department of Defense as part of a multi-institutional Transformative Breast Cancer Consortium. The award will fund research on the... Read more
Investigators at Weill Cornell Medicine have identified significant differences in the molecular characteristics of tumors from younger and older cancer patients across several cancer types. Their research, published Dec. 7... Read more
The National Human Genome Research Institute has funded a multi-institutional Center of Excellence in Genome Sciences (CEGS) , based at Weill Cornell Medicine, to develop new tools to study the major product of the human... Read more
Treatment with arginine, one of the amino-acid building blocks of proteins, enhanced the effectiveness of radiation therapy in cancer patients with brain metastases, in a proof-of-concept, randomized clinical trial from... Read more
Lymphomas can turbo-charge their ability to proliferate by crowding growth-supporting enzymes into highly concentrated compartments within tumor cells, according to a study led by researchers at Weill Cornell Medicine. The... Read more
A team led by researchers at Weill Cornell Medicine, the New York Genome Center , Harvard Medical School , Massachusetts General Hospital and the Broad Institute of MIT and Harvard has profiled in unprecedented detail... Read more
Illustration of B cells, antibodies and red blood cells. Credit: Shutterstock The master regulator behind the development of antibody-producing cells has been identified in a study by investigators at Weill Cornell Medicine... Read more
Multiplex immunofluorescence image of immune cell-infiltrated human colorectal cancer. Tumor cells are labeled with PKCi (magenta), immune cells are labeled with CD8 (red) and nuclei in white. Image courtesy of Dr. Jorge... Read more
Primary Image Description & Credit: Immunofluorescent images of lungs treated with radiation (left) or no radiation (right). Club cells secrete more anti-immunosuppressive factors when treated with radiation, as seen by... Read more
A team co-led by scientists at Weill Cornell Medicine has revealed in detail how the most common primary eye cancer in adults, uveal melanoma (UM), can progress from a slow-growing, “indolent” state to a lethal metastasizing... Read more
Cheryl Bonder had been living with a vaguely defined blood malignancy for years when her prognosis rapidly took a turn for the worse: her condition was progressing toward acute myelogenous leukemia (AML), an aggressive... Read more
Left: Low and high magnification images of small intestine from healthy mice treated with water or high-fructose corn syrup for 4 weeks. Right: Schematic illustrating how fructose promotes cell survival and increased villi... Read more
An immune cell subset called innate lymphoid cells (ILC3s) protects against colorectal cancer, in part by helping to maintain a healthy dialogue between the immune system and gut microbes, according to a new study led by... Read more
A new treatment for advanced urothelial cancer was effective with tolerable side effects in an international, multi-center phase 2 clinical trial led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. The... Read more
A powerful immune-suppressing molecule produced by the body may hold the key to better treatments for autoimmune and inflammatory diseases, as well as for some cancers, according to a study by researchers at Weill Cornell... Read more
A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital. The preclinical results... Read more
